EMEA-000597-PIP03-15-M03

Key facts

Invented name
Betmiga
Active substance
Mirabegron
Therapeutic area
Uro-nephrology
Decision number
P/0288/2016
PIP number
EMEA-000597-PIP03-15-M03
Pharmaceutical form(s)
Prolonged-release granules for oral suspension
Condition(s) / indication(s)
Treatment of neurogenic detrusor overactivity
Route(s) of administration
Oral use
Contact for public enquiries
Astellas Pharma Europe B.V.
The Netherlands
Tel. +31 7154 55878
Fax +31 7154 55224
E-mail: contact@nl.astellas.com
 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating